Results 271 to 280 of about 167,693 (338)

A Rare Case Report of an Adult With Intraspinal Gouty Stones and Concurrent Knee Joint Involvement

Clinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT This case highlights the importance of considering spinal gout in patients with hyperuricemia presenting with atypical back pain or neurological symptoms. Multidisciplinary surgical management, including decompression and joint arthroscopy, combined with urate‐lowering therapy and lifestyle modifications, can achieve significant symptom relief
Bo Cao, Jinlong Wang
wiley   +1 more source

Response to Prof. Jose Berciano's Letter to the Editor on "Intravenous Methylprednisolone in Guillain-Barré Syndrome: The Way Forward?" [PDF]

Ann Indian Acad Neurol
Prasad K.
europepmc   +1 more source

Methylprednisolone Does Not Decrease Eicosanoid Concentrations or Edema in Brain Tissue or Improve Neurologic Outcome After Head Trauma in Rats

, 1992
Yoram Shapira, Alan A. Artru, Gal Yadid, E. Shohami   +3 more
openalex   +1 more source

Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV‐Positive Patient: A Case Report

Clinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Managing immune thrombocytopenia (ITP) in HIV patients remains challenging due to refractory cases and treatment limitations. This report highlights fostamatinib as a safe, effective, and antiretroviral therapy‐compatible option, offering durable platelet stabilization in a difficult‐to‐treat population.
Matteo Bellia, Riccardo Moia, Mattia Schipani, Carola Sella, Mariangela Greco, Wael Al Essa, Abdurraouf Mokhtar Mahmoud, Gianluca Gaidano, Andrea Patriarca   +8 more
wiley   +1 more source

Methylprednisolone Protects Human Pancreatic Beta Cells From Inflammation-induced Damage. [PDF]

Transplant Direct
Paz-Barba M, Peters IJA, de Graaf N, Carlotti F, de Koning EJP.   +4 more
europepmc   +1 more source

Uncovering New Therapeutic Targets for Amyotrophic Lateral Sclerosis and Neurological Diseases Using Real‐World Data

Clinical Pharmacology &Therapeutics, Volume 118, Issue 1, Page 242-251, July 2025.
Although attractive for relevance to real‐world scenarios, real‐world data (RWD) is typically used for drug repurposing and not therapeutic target discovery. Repurposing studies have identified few effective options in neurological diseases such as the rare disease, amyotrophic lateral sclerosis (ALS), which has no disease‐modifying treatments ...
Mohammadali Alidoost, Jeremy Y. Huang, Georgia Dermentzaki, Anna S. Blazier, Giorgio Gaglia, Timothy R. Hammond, Francesca Frau, Mary Clare McCorry, Dimitry Ofengeim, Jennifer L. Wilson   +9 more
wiley   +1 more source

Ultrastructural nuclear changes in leukemic L1210 and normal thymocyte treated with adriamycin of anticancer agent and methylprednisolone of apoptotic agent.

, 1993
Aki Yoshikawa, Guangxun Tian, Ken-ichi Kiyomiya, Saburo Matsuo, Masaru Kurebe   +4 more
openalex   +1 more source

The effect of pre‐operative methylprednisolone on early endothelial damage after total knee arthroplasty: a randomised, double‐blind, placebo‐controlled trial

Anaesthesia, 2017
Viktoria Lindberg-Larsen, S. Ostrowski, M. Lindberg-Larsen, M. Rovsing, Pär I. Johansson, Pär I. Johansson, Henrik Kehlet   +6 more
semanticscholar   +1 more source

Enfortumab Vedotin–Induced Toxic Epidermal Necrolysis in Metastatic Urothelial Carcinoma Complicated by Severe Gastrointestinal Bleeding

IJU Case Reports, Volume 8, Issue 4, Page 348-351, July 2025.
ABSTRACT Introduction Enfortumab vedotin (EV) has been reported to cause skin toxicity in some patients. We report a rare case of toxic epidermal necrolysis (TEN) induced by EV and complicated by severe gastrointestinal (GI) bleeding. Case Presentation A 70‐year‐old man with recurrent urothelial carcinoma developed a trunk rash at 16 days after EV ...
Aika Matsuyama, Takashi Kato, Rion Kawase, Mikinori Kobayashi, Ayako Momota, Yukiko Tsunoda, Asaomi Yamaguchi, Hiroki Hirabayashi, Shoji Suzuki, Masashi Kato   +9 more
wiley   +1 more source

Corticosteroids in posterior reversible encephalopathy syndrome: Friend or foe? A systematic review. [PDF]

World J Clin Cases
Srichawla BS, Kaur T, Singh H.
europepmc   +1 more source